Star
26 583 babies born at "Nadezhda"
0 Baloons

gynaecology

Ziwig Endotest – a saliva test for early and reliable diagnosis of endometriosis

Ziwig Endotest is an innovative, non-invasive test that uses a saliva sample to help detect endometriosis in its early stages, even when ultrasound or other imaging methods show no abnormalities.

Do you have symptoms of endometriosis?

Endometriosis is one of the most common gynecological conditions in women of reproductive age. Globally, it affects approximately 1 in 10 women, yet diagnosis is often significantly delayed. In many cases, it takes an average of 7 to 11 years before women understand the cause of their symptoms, which can seriously impact daily life, work capacity, and overall quality of life.

 

One of the reasons for delayed diagnosis is that endometriosis cannot always be detected through standard imaging techniques, especially in the early stages. In response to this challenge, “Nadezhda” Hospital introduces Ziwig Endotest – the first non-invasive test for diagnosing endometriosis in Bulgaria.

If you recognize several of the following symptoms, they may be related to endometriosis:

What is endometriosis?

Endometriosis is a chronic condition in which tissue similar to the lining of the uterus grows outside the uterine cavity.

It most commonly affects:

  • ovaries
  • fallopian tubes
  • intestines
  • bladder

These cells respond to hormonal changes during the menstrual cycle, which can lead to inflammation, pain, and the formation of adhesions.

Early diagnosis is essential for choosing appropriate treatment and improving patients’ quality of life.

What is Ziwig Endotest

Ziwig Endotest is a first step toward a clearer diagnosis, better symptom control, and improved quality of life.

 

The test analyzes a broad panel of microRNA markers using next-generation sequencing (NGS) technology and artificial intelligence. This enables identification of the specific molecular “signature” of endometriosis. Thanks to this approach, the test can detect disease biomarkers even when ultrasound or other imaging methods show no abnormalities.

Who is the test suitable for?

Ziwig Endotest is intended for patients aged 18 to 43 who have symptoms suggestive of endometriosis:

  • severe menstrual pain
  • chronic pelvic pain
  • pain during intercourse
  • heavy or prolonged menstrual cycles
  • difficulty conceiving
  • digestive complaints that worsen during the menstrual cycle

Symptoms often begin in adolescence but may be underestimated or misinterpreted for years.

Test conditions

To undergo the test, you must first visit the Registration Desk at “Nadezhda” Hospital or the “Nadezhda” Medical Center (Paradise Center, floor 3) to pay for the test and be directed to the Clinical Laboratory, where you will provide a saliva sample and review the informed consent form.

You must be in good health and, at least 30 minutes before the test:

  • do not eat or drink
  • do not smoke
  • do not brush your teeth
  • do not chew gum
  • do not wear lipstick

These requirements ensure a clean saliva sample for accurate molecular analysis.

Advantages of Ziwig Endotest

  • non-invasive diagnosis using a saliva sample
  • completely painless procedure
  • possibility for early detection, even with normal ultrasound findings
  • high diagnostic accuracy – sensitivity >97%, specificity >93%

IMPORTANT! Ziwig Endotest does not replace consultation with a specialist but is a valuable tool for earlier diagnosis.

Importance of early diagnosis

Timely detection of endometriosis allows for:

  • earlier initiation of appropriate treatment
  • better pain management
  • limitation of disease progression
  • preservation of reproductive potential

Early diagnosis helps many women regain control over their health and quality of life.

Experience of the team at Nadezhda Hospital

Dr. Georgi Stamenov and his team have extensive experience in diagnosing and treating endometriosis. Their work is based on careful observation, in-depth medical expertise, and an individualized approach to each patient.

 

Nadezhda Hospital consistently implements the most advanced medical technologies, and the introduction of Ziwig Endotest is part of its commitment to providing gentler diagnostics for this common yet often underestimated condition.

Frequently Asked Questions

Ziwig Endotest is based on solid clinical evidence, including validation through one of the largest clinical studies in the field of endometriosis biomarkers – the multicenter prospective ENDOmiRNA Saliva Test (NCT05244668).
Clinical studies show over 95% diagnostic accuracy.

The test is designed to detect endometriosis at all stages, including early forms. It analyzes a specific microRNA profile in saliva, enabling detection even without visible lesions on imaging.

Yes. It is particularly useful for patients with normal imaging but with symptoms such as chronic pelvic pain or other clinical signs suggestive of endometriosis.

The test costs €1800 / 3,520.49 BGN.

Results are available within up to 15 working days after the sample arrives at the manufacturer’s laboratory in France.

The test is non-invasive (saliva-based) and may support earlier diagnosis. A positive result does not replace clinical evaluation but is a strong diagnostic indicator that can help guide decisions on medical or hormonal therapy, as well as the need for further diagnostic or surgical procedures.

The test is usually prescribed by a gynecologist or reproductive specialist who evaluates the clinical indications.

After laboratory analysis, the results are uploaded to the patient’s hospital profile and discussed with the treating physician, who determines the next steps—treatment, additional tests, or surgical intervention.

See also

Preventive gynaecology

Сива стрелка надясно

Medication abortion

Сива стрелка надясно

Aesthetic gynaecology

Сива стрелка надясно

Reproductive surgery

Сива стрелка надясно
scroll-top-custom-arrow